From Mn3O4/MnO core-shell nanoparticles to hollow MnO: evolution of magnetic properties

Magnetic Properties of Bi-Magnetic Core/Shell Nanoparticles: The Case of Thin Shells

Bi-magnetic core/shell nanoparticles were synthesized by a two-step high-temperature decomposition method of metal acetylacetonate salts. Transmission electron microscopy confirmed the formation of an ultrathin shell (~0.6 nm) of NiO and NiFe2O4 around the magnetically hard 8 nm CoFe2O4 core nanoparticle. Magnetization measurements showed an increase in the coercivity of the single-phase CoFe2O4 seed nanoparticles from ~1.2 T to ~1.5 T and to ~2.0 T for CoFe2O4/NiFe2O4 and CoFe2O4/NiO, respectively. The NiFe2O4 shell also increases the magnetic volume of particles and the dipolar interparticle interactions. In contrast, the NiO shell prevents such interactions and keeps the magnetic volume almost unchanged.

Tuneable manganese oxide nanoparticle based theranostic agents for potential diagnosis and drug delivery

Among various magnetic nanoparticles, manganese oxide nanoparticles are considered as established T ₁ magnetic resonance imaging (MRI) contrast agents for preclinical research. The implications of their degradation properties and use as therapeutic carriers in drug delivery systems have not been explored. In addition, how the chemical composition and size of manganese oxide nanoparticles, as well as the surrounding environment, influence their degradation and MRI contrast properties (T ₁ vs. T ₂) have not been studied in great detail. A fundamental understanding of their characteristic properties, such as degradation, is highly desirable for developing simultaneous diagnosis and therapeutic solutions. Here, we demonstrate how the precursor type and reaction environment affect the size and chemical composition of manganese oxide nanoparticles and evaluate their influence on the nanoparticle degradability and release of the drug l-3,4-dihydroxyphenylalanine (l-dopa). The results show that the degradation rate (and the associated release of drug l-dopa molecules) of manganese oxide nanoparticles depends on their size, composition and the surrounding environment (aqueous or biometric fluid). The dependence of MRI relaxivities of manganese oxide nanoparticles on the size, chemical composition and nanoparticle degradation in water is also established. A preliminary cell viability study reveals the cytocompatible properties of l-dopa functionalized manganese oxide nanoparticles. Overall, this work provides new insights into smartly designed manganese oxide nanoparticles with multitasking capabilities to target bioimaging and therapeutic applications.

The role of chemical and microstructural inhomogeneities on interface magnetism

The study of interfacing effects arising when different magnetic phases are in close contact has led to the discovery of novel physical properties and the development of innovative technological applications of nanostructured magnetic materials. Chemical and microstructural inhomogeneities at the interfacial region, driven by interdiffusion processes, chemical reactions and interface roughness may significantly affect the final properties of a material and, if suitably controlled, may represent an additional tool to finely tune the overall physical properties. The activity at the Nanostructured Magnetic Materials Laboratory (nM²-Lab) at CNR-ISM of Italy is aimed at designing and investigating nanoscale-engineered magnetic materials, where the overall magnetic properties are dominated by the interface exchange coupling. In this review, some examples of recent studies where the chemical and microstructural properties are critical in determining the overall magnetic properties in core/shell nanoparticles, nanocomposites and multilayer heterostructures are presented.